Search clinical trials for: with 0,5% oxalic acid (Desenssiv SSWhite)
Total 26 results
-
Agricultural University of AthensCompletedAppetitive Behavior | Potential Abnormality of Glucose ToleranceGreece
-
Yuzuncu Yıl UniversityActive, not recruitingImpacted Third Molar ToothTurkey
-
TakedaCompleted
-
Hospital Universitario Virgen de la ArrixacaUnknownCritical Illness | Mechanical Ventilation Complication | Tracheostomy Complication | Plug; MucusSpain
-
Roswell Park Cancer InstituteCephalon, Inc.TerminatedPrimary Myelofibrosis | Polycythemia Vera | Essential ThrombocythemiaUnited States
-
Ain Shams UniversityCompleted
-
Centro Ortopedico y Quirurgico del PieCompleted
-
University Medical Center MainzCompletedNeurological Autoimmune DiseasesGermany
-
Ashutosh Kumar TewariOncovir, Inc.Completed
-
Supplement Formulators, Inc.CompletedBody Weight ChangesUnited States
-
Assistance Publique - Hôpitaux de ParisNovartisCompleted
-
University of California, San DiegoUniversity of California, Los Angeles; Society of Family PlanningCompletedAbortion in First Trimester | Abortion, Spontaneous | Abortion, Missed | Abortion Early | Pain UterusUnited States
-
Ramathibodi HospitalCompletedRadical MastectomyThailand
-
Children's Oncology GroupNational Cancer Institute (NCI)Not yet recruitingMetastatic Osteosarcoma | Localized Osteosarcoma | Unresectable Osteosarcoma | Resectable Osteosarcoma
-
University of NebraskaNational Cancer Institute (NCI)TerminatedGlioma | GlioblastomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Rectal Carcinoma | Stage IIIA Rectal Cancer AJCC v7 | Stage IIIB Rectal Cancer AJCC v7 | Stage IIIC Rectal Cancer AJCC v7 | Stage IVA Rectal Cancer AJCC v7 | Stage IVB Rectal Cancer AJCC v7 | Rectal Mucinous Adenocarcinoma | Rectal Signet Ring Cell Adenocarcinoma | Stage IIA Rectal Cancer... and other conditionsUnited States
-
University Hospital, GenevaCompletedKeratitis; Infectious Disease (Manifestation)Switzerland
-
Children's Oncology GroupNational Cancer Institute (NCI)RecruitingRecurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Recurrent B Lymphoblastic Lymphoma | Refractory B Lymphoblastic LymphomaUnited States, Puerto Rico
-
Children's Oncology GroupNational Cancer Institute (NCI); EsPhALL Network/ BFM Study GroupRecruitingAcute Lymphoblastic Leukemia | B Acute Lymphoblastic Leukemia | T Acute Lymphoblastic Leukemia | Mixed Phenotype Acute LeukemiaUnited States, Canada, Puerto Rico, Australia, Finland, New Zealand, Saudi Arabia, Germany, Austria, Belgium, Chile, Czechia, France, Italy, Netherlands, Sweden, Switzerland, Hong Kong, Israel
-
National Cancer Institute (NCI)Not yet recruiting
-
Children's Oncology GroupNational Cancer Institute (NCI)RecruitingB Acute Lymphoblastic Leukemia | Central Nervous System Leukemia | Testicular Leukemia | B Lymphoblastic Lymphoma | Mixed Phenotype Acute LeukemiaUnited States, Canada, Australia, Puerto Rico, New Zealand
-
Children's Oncology GroupRecruitingRecurrent Acute Lymphoblastic Leukemia | Refractory Acute Lymphoblastic Leukemia | Recurrent Mixed Phenotype Acute Leukemia | Refractory Mixed Phenotype Acute Leukemia | Refractory Acute Leukemia of Ambiguous Lineage | Recurrent Acute Leukemia of Ambiguous Lineage | Recurrent Acute Myeloid Leukemia... and other conditionsUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedAcute Lymphoblastic Leukemia | Adult B Acute Lymphoblastic Leukemia | Childhood B Acute Lymphoblastic LeukemiaUnited States
-
National Cancer Institute (NCI)WithdrawnT Acute Lymphoblastic Leukemia | T Lymphoblastic Lymphoma
-
National Cancer Institute (NCI)Not yet recruitingB Acute Lymphoblastic Leukemia | Acute Leukemia of Ambiguous Lineage